AIDS vaccine research blown away by Yale's Pam3Cys/LYMErix lies

[Mort Zuckerman]

To: emcsw...@nasw.org, zerh...@od.nih.gov,
Spin...@yahoogroups.com, kshe...@calea.org, fit...@gmail.com,
patrick.f...@usdoj.gov, model...@sbcglobal.net,
jdr...@nejm.org, let...@courant.com, Jgerb...@cdc.gov,
michae...@po.state.ct.us, con...@po.state.ct.us, executive-
edi...@nytimes.com, managin...@nytimes.com, news-
ti...@nytimes.com, the-...@nytimes.com, biz...@nytimes.com,
for...@nytimes.com, me...@nytimes.com, nati...@nytimes.com,
dv...@cdc.gov, brigidc...@optonline.net, tr...@hotmail.com,
illino...@aol.com, jle...@courant.com, tinaj...@yahoo.com,
jhorn...@fff.org, thomas...@usdoj.gov,
thoma...@po.state.ct.us, kur...@washpost.com,
georg...@washpost.com, p...@allegorypress.com,
commissi...@po.state.ct.us, FalN...@aol.com,
brans...@comcast.net, vts...@comcast.net, o...@po.state.ct.us,
freet...@charter.net, scott....@po.state.ct.us,
govern...@po.state.ct.us, attorney...@po.state.ct.us,
randall...@usdoj.gov
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, hor...@courant.com,
bmi...@newstimes.com, tr...@hotmail.com, rast...@aol.com,
billc...@gmail.com, amcg...@rms-law.com, rjmu...@aol.com,
paulcrai...@yahoo.com, sidney_b...@yahoo.com,
criminal...@usdoj.gov, karla.d...@usdoj.gov,
christophe...@usdoj.gov, richar...@yale.edu,
harol...@yale.edu, james.p...@yale.edu, inq...@aldf.com,
ly...@idsociety.org

Subject: AIDS vaccine research blown away by Yale's Pam3Cys/LYMErix
lies

Date: Oct 19, 2008 1:33 PM

Um, no. (ARTICLE BELOW)

Yale could have looked into the matter
of why LYMErix failed rather than had a stated
campaign to blow-off the immune suppression
http://www.actionlyme.org/SCHOEN_INSTRUCTING_DOCS_TO_BLOW_OFF_LYMERIX_INJUREES.htm
(Great Imitator) outcomes. They decided they would
deny the existence of because BigInsurance did not
want to pay for IV treatment (establishment of
the ALDF.com by Kaiser Permanente, Gary Wormser
John J. Connolly, Durlanf Fish, and Edward McSweegan):
http://www.actionlyme.org/CONNOLLY_FISH_WEINSTEIN.htm
http://www.actionlyme.org/ALDF_BOARD.htm
http://www.actionlyme.org/GOLDWATER_LETTER.htm

World's Stupidest Scientists.


The Pam3Cys-induced immune suppression and HIV
explainer (not in Pam Weintraub's book, making
her book already outdated):
http://www.actionlyme.org/PAM3CYS_IMMUNE_SUPPRESSION.htm

TLR2-tolerance, downregulation of HLA, caspase inhibition,
Pam3Cys-induced B cell mutations (EBV-like immortilization),
and tolerance to similar fungal antigens.

Paul Duray told IDSA about it in 1989 and 1992:
http://www.actionlyme.org/Duray.htm
http://www.actionlyme.org/IDSA_CLINIPATH_DURAY.htm


There is no excuse for Yale's Lyme and LYMErix crimes, whatsoever.

The data was available all along, since I looked into the
matter of what happened to previous fungal vaccines - knowing
what LYMErix did, since I was a support group leader and was
on the receiving end of the calls of the LYMErix disease victims -
which also *ALL* *FAILED* like LYMERIX and the HIV vaccines.

The data was there. I knew what to look for and
I found it.

Yale staff didn't care about humans.

EVER:
http://www.actionlyme.org/Schoen.htm
http://www.actionlyme.org/PHILLIPS_JE_PERVERT.htm
http://www.actionlyme.org/LEEBENS_DEFRAUDING_THE_COURT.htm
http://www.actionlyme.org/MARCUS_DANGEROUS_INCOMPETENCE.htm


Kathleen M. Dickson
"Dangerously Intelligent"
http://www.relapsingfever.org
===============================

http://rawstory.com/news/2008/After_setbacks_hunt_for_AIDS_vaccine_1019.html
After setbacks, hunt for AIDS vaccine pushes on
Agence France-Presse
Published: Sunday October 19, 2008

Buzz up!vote now


Print This Email This

CAPE TOWN, (AFP) – One year after a puzzling setback in the hunt for
an AIDS vaccine,
researchers say their defeats have forced them to look for entirely
new ways of
creating a defence against the disease.

After nearly 30 years, 25 million deaths and billions of dollars spent
with no vaccine
to show for it, scientists at this year's international AIDS Vaccine
Conference
said they were turning to novel approaches to overcome their defeats.

"We are in the middle of quite a profound shift of mindset in the
research
community," said Alan Bernstein, director of the Global HIV Vaccine
Enterprise,
an alliance of organisations working on a vaccine.

Speaking to AFP on the sidelines of the meeting that ended Friday in
Cape Town,
he said that startling setbacks had forced scientists to delve into
sophisticated
new research to tackle the disease.

Last year scientists were forced to abandon two advanced clinical
trials of a vaccine
by pharmaceutical company Merck, after it appeared to actually
heighten the risk
of AIDS infection.

"The Merck result was such a surprise and everyone was kind of knocked
off
their horses... What happened no one could have predicted," Mitchell
Warren
of the AIDS Vaccine Advocacy Coalition said.

"They still don't understand exactly what happened. That finding
forces
people to realign and look at new ways and new approaches to how we
are going to
find an AIDS vaccine because it was so surprising."

About 30 other clinical trials are underway around the world, but the
most watched
is a study in Thailand that began in 2003, with results expected next
year.

That study is the biggest ever, with 16,000 people enrolled.
Scientists say that
whatever the outcome, it will provide valuable information on the
pandemic, which
most agree won't see a vaccine for decades.

Meanwhile, Warren says the failure of the Merck trial has already
forced scientists
to rethink their basic assumptions about how vaccines work.

"People are really grappling with new ways of doing things," he said.

In the past vaccines have either caused the body to develop antibodies
that kill
a disease, or to attack infected cells to kill them off before a
disease spreads.

But HIV mutates at every turn, making it almost impossible to design a
vaccine to
attack it.

Bernstein said the most exciting new research involves newly
discovered defences
in the human body called the innate immune system, which serves as an
early warning
system for invading diseases.

That system could provide a way to stop HIV, if scientists found a way
to trigger
it early enough, he said.

"We now know we may have only hours, at most days, before we have a
window
of opportunity to stop HIV. So that's reason to think this early
warning system
might be critical to activate if we are going to design a vaccine," he
said.

The disappointments in the quest for a vaccine have sparked calls for
an end to
the research, with critics arguing the money could be better spent on
other prevention
or treatment efforts.

But Anthony Fauci, one of the world's top AIDS researchers at the US
National
Institutes of Health, insisted that a vaccine would eventually provide
the world's
best defence against the disease.

The NIH, the main global funder of HIV vaccine research, spent 1.5
billion on the
field in 2008.

"If you look historically, vaccines have been the most cost-effective
health
interventions in history," by preventing the incredible financial
burden of
treating diseases, Fauci said.